Ibio Inc (NYSEMKT:IBIO) just announced and agreement to broaden their commercial collaboration, currently focused on antibodies and certain vaccine products, to include iBio’s proprietary IBIO-CFB03 product...
IFAN Financial Inc (OTCBB:IFAN) hit the OTCBB at $0.20 in the beginning of October fresh off the name change from Infantly Available Inc and has been...